Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome

Research in Developmental Disabilities

Volumn 34, Issue 5, 2013, Pages 1700-1709

  Martens, Marilee A ^a,b   Seyfer, Daisha L ^c   Andridge, Rebecca R ^d   Foster, Jessica E A ^e   McClure, Kelsey E ^d   Coury, Daniel L ^f  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Sanford Children's Specialty Clinic   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO DEPARTMENT OF HEALTH   (United States)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

ADHD medication; Amphetamine; Methylphenidate; Stimulant medication; Williams syndrome

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; LISDEXAMFETAMINE; METHYLPHENIDATE;

ADOLESCENT; ADULT; ANXIETY DISORDER; AORTA COARCTATION; AORTA SUPRAVALVULAR STENOSIS; AORTA VALVE DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLOOD PRESSURE; CARDIOMYOPATHY; CARDIOTOXICITY; CAREGIVER; CHILD; CONTROLLED STUDY; COOPERATION; DEPRESSION; DRUG CLASSIFICATION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FAINTNESS; FALLOT TETRALOGY; FEMALE; FIGHTING; HALLUCINATION; HEART ATRIUM SEPTUM DEFECT; HEART PALPITATION; HEART RATE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MITRAL VALVE DISEASE; OPPOSITIONAL DEFIANT DISORDER; PARENT; PRESCHOOL CHILD; PRESCRIPTION; PULMONARY ARTERY STENOSIS; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; STOMACH PAIN; TOOTH DISEASE; TREMOR; WEIGHT REDUCTION; WILLIAMS BEUREN SYNDROME;

ADOLESCENT; AMPHETAMINES; AORTIC STENOSIS, SUBVALVULAR; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAREGIVERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INFANT; MALE; MENTAL DISORDERS; METHYLPHENIDATE; PREVALENCE; PULMONARY VALVE STENOSIS; WILLIAMS SYNDROME; YOUNG ADULT;

EID: 84875066336     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2013.02.015     Document Type: Article

References (46)

1. Ahmann P.A., Waltonen S.J., Olson K.A., Theye F.W., Van Erem A.J., LaPlant R.J. Placebo-controlled evaluation of Ritalin side effects. Pediatrics 1993, 91:1101-1116.
2. Axelsson S., Bjørnland T., Kjaer I., Heiberg A., Storhaug K. Dental characteristics in Williams syndrome: A clinical and radiographic evaluation. Acta Odontologica Scandinavica 2003, 61:129-136.
3. Barbaresi W.J., Katusic S.K., Colligan R.C., Pankratz V.S., Weaver A.L., Weber K.J., et al. How common is attention-deficit/hyperactivity disorder?: Incidence in a population-based birth cohort in Rochester, Minn. Archives of Pediatrics & Adolescent Medicine 2002, 156:217-224.
4. Barkley R., McMurray M., Edelbrock C., Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic placebo-controlled evaluation. Pediatrics 1990, 86:184-192.
5. Bawden H.N., MacDonald G.W., Shea S. Treatment of children with Williams syndrome with methylphenidate. Journal of Child Neurology 1997, 12:248-252.
6. Bimstein E., Wilson J., Guelmann M., Primosch R. Oral characteristics of children with attention-deficit hyperactivity disorder. Special Care in Dentistry 2008, 28:107-110.
7. Broadbent J.M., Ayers K.M., Thomson W.M. Is attention-deficit hyperactivity disorder a risk factor for dental caries? A case-control study. Caries Research 2004, 38:29-33.
8. Chandra P., Anandakrishna L., Ray P. Caries experience and oral hygiene status of children suffering from attention deficit hyperactivity disorder. Journal of Clinical Pediatric Dentistry 2009, 34:25-29.
9. Cherniske E.M., Carpenter T.O., Klaiman C., Young E., Bregman J., Insogna K., et al. Multisystem study of 20 older adults with Williams syndrome. American Journal of Medical Genetics Part A 2004, 131A:255-264.
10. Cuffe S.P., Mckeown R.E., Jackson K.L., Addy C.L., Abramson R., Garrison C.Z. Prevalence of attention-deficit/hyperactivity disorder in a community sample of older adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 2001, 40:1037-1044.
11. Dekker M.C., Koot H.M., Ende J.V.D., Verhulst F.C. Emotional and behavioral problems in children and adolescents with and without intellectual disability. Journal of Child Psychology and Psychiatry 2002, 43:1087-1098.
12. Einfeld S.L., Tonge B.J., Rees V.W. Longitudinal course of behavioral and emotional problems in Williams syndrome. American Journal on Mental Retardation 2001, 106:73-81.
13. Einfeld S., Tonge B., Florio T. Behavioral and emotional disturbance in individuals with Williams syndrome. American Journal on Mental Retardation 1997, 102:45-53.
14. Elison S., Stinton C., Howlin P. Health and social outcomes in adults with Williams syndrome: Findings from cross-sectional and longitudinal cohorts. Research in Developmental Disabilities 2010, 31:587-599.
15. Emerson E., Einfeld S. Emotional and behavioural difficulties in young children with and without developmental delay: A bi-national perspective. Journal of Child Psychology and Psychiatry 2010, 51:583-593.
16. Eronen M., Peippo M., Hiippala A., Raatikka M., Arvio M., Johansson R., et al. Cardiovascular manifestations in 75 patients with Williams syndrome. Journal of Medical Genetics 2002, 39:554-558.
17. Findling R.L., Short E.J., Manos M.J. Short-term cardiovascular effects of methylphenidate and adderall. Journal of the American Academy of Child & Adolescent Psychiatry 2001, 40:525-529.
18. Friedlander A.H., Yagiela J.A., Mahler M.E., Rubin R. The pathophysiology medical management and dental implications of adult attention-deficit/hyperactivity disorder. The Journal of the American Dental Association 2007, 138:475-482.
19. Green T., Avda S., Dotan I., Zarchi O., Basel-Vanagaite L., Zalsman G., et al. Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2011, 159B:13-20.
20. Greenhill L.L., Muniz R., Ball R.R., Levine A., Pestreich L., Jiang H. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2006, 45:817-823.
21. Greer M., Pai B.F., Choudry G., Klein S.A. Cognitive, adaptive and behavioral characteristics of Williams syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 1997, 74:521-525.
22. Grooms M.T., Keels M.A., Roberts M.W., McIver F.T. Caries experience associated with attention-deficit/hyperactivity disorder. Journal of Clinical Pediatric Dentistry 2005, 30:3-7.
23. Guggenheimer J., Moore P.A. Xerostomia: Etiology recognition and treatment. The Journal of the American Dental Association 2003, 134:61-69.
24. Hammerness P.G., Perrin J.M., Shelley-Abrahamson R., Wilens T.E. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: Update and clinical recommendations. Journal of the American Academy of Child & Adolescent Psychiatry 2011, 50:978-990.
25. Handen B.L., Feldman H., Gosling A., Breaux A.M., McAuliffe S. Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 1991, 30:241-245.
26. Handen B.L., Feldman H.M., Lurier A., Murray P.J. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 1999, 38:805-812.
27. Hertzberg J., Nakisbendi L., Needleman H.L., Pober B.R. Williams syndrome-Oral presentation of 45 cases. Pediatric Dentistry 1994, 16:262-267.
28. Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., et al. The DNA sequence of human chromosome 7. Nature 2003, 424:157-164.
29. Katz-Sagi H., Redlich M., Brinsky-Rapoport T., Matot I., Ram D. Increased dental trauma in children with attention deficit hyperactivity disorder treated with methylphenidate-A pilot study. Journal of Clinical Pediatric Dentistry 2010, 34:287-289.
30. Leyfer O.T., Woodruff-Borden J., Klein-Tasman B.P., Fricke J.S., Mervis C.B. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:615-622.
31. Martens M.A., Wilson S.J., Reutens D.C. Research review: Williams syndrome: A critical review of the cognitive, behavioral and neuroanatomical phenotype. The Journal of Child Psychology and Psychiatry 2008, 49:576-608.
32. Mervis C.B., Klein-Tasman B.P. Williams syndrome: Cognition, personality and adaptive behavior. Mental Retardation and Developmental Disabilities Research Reviews 2000, 6:148-158.
33. Neece C.L., Baker B.L., Blacher J., Crnic K.A. Attention-deficit/hyperactivity disorder among children with and without intellectual disability: An examination across time. Journal of Intellectual Disability Research 2011, 55:623-635.
34. Neuman R.J., Sitdhiraska N., Reich W., Ji T.H., Joyner C.A., Sun L.W., et al. Estimation of prevalence of DSM-IV and latent class-defined ADHD subtypes in a population-based sample of child and adolescent twins. Twin Research and Human Genetics 2005, 8:392-401.
35. Pham P.P., Moller J.H., Hills C., Larson V., Pyles L. Cardiac catheterization and operative outcomes from a multicenter consortium for children with Williams syndrome. Pediatric Cardiology 2009, 30:9-14.
36. Physicians' desk reference 2012, Physicians' Desk Reference Inc., Montvale, NJ. 66th ed.
37. Power T.J., Blum N.J., Jones S.M., Kaplan P.E. Brief report: Response to methylphenidate in two children with Williams syndrome. Journal of Autism and Developmental Disorders 1997, 27:79-87.
38. Rapport M.D., Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate: A review of height/weight, cardiovascular and somatic complaint side effects. Clinical Psychology Review 2002, 22:1107-1131.
39. Rhodes S.M., Riby D.M., Park J., Fraser E., Campbell L.E. Executive neuropsychological functioning in individuals with Williams syndrome. Neuropsychologia 2010, 48:1216-1226.
40. Safer D.J. Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 1992, 2:279-290.
41. Stiefel G., Besag F.M. Cardiovascular effects of methylphenidate amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Safety 2010, 33:821-842.
42. Strømme P., Bjømstad P.G., Ramstad K. Prevalence estimation of Williams syndrome. Journal of Child Neurology 2002, 17:269-271.
43. Sugayama S.M., Moisés R.L., Wagënfur J., Ikari N.M., Abe K.T., Leone C., et al. Williams-Beuren syndrome: Cardiovascular abnormalities in 20 patients diagnosed with fluorescence in situ hybridization. Arquivos Brasileiros de Cardiologia 2003, 81:468-743.
44. Waxler J.L., Levine K., Pober B.R. Williams syndrome: A multidisciplinary approach to care. Pediatric Annals 2009, 38:456-463.
45. Xie C.H., Zhao Z.Y., Yang J.B., Qin Y.F., Shao J., Gong F.Q. Cardiovascular manifestations in 40 patients with Williams syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:904-907.
46. Zwaigenbaum L., Dick P., Handley-Derry M., Malone M., Jacobson S. "N of 1" trials of methylphenidate in two children with Williams syndrome and attention deficit hyperactivity disorder. Journal of Developmental and Physical Disabilities 2006, 18:45-58.